Low doses of methylnaloxonium in the nucleus accumbens antagonize hyperactivity induced by heroin in the rat

https://doi.org/10.1016/0091-3057(85)90014-0Get rights and content

Abstract

The effect of microinjection of a quaternary opiate antagonist methylnaloxonium (MN) in the lateral ventricle, ventral tegmental area (VTA) and nucleus accumbens (N.Acc.) was examined on the locomotor activation produced by a subcutaneous heroin injection (0.5 mg/kg) in the rat. At this dose heroin typically produced an initial depressant phase (0–30 min) followed by a prolonged hyperactivity (40–120 min). Lateral ventricular injections did not significantly reverse the initial depressant effects of heroin (0–30 min), and a dose of 4 μg was needed to reverse the subsequent hyperactivity (40–120 min). The most potent blockade was observed following injections into the N.Acc. where 0.1 μg significantly reversed the initial depressant effects of heroin (0–30 min), and 0.25 μg significantly reversed the subsequent hyperactivity (40–120 min). In the VTA, MN had the weakest effects, failing to reverse significantly the initial depressant effects of heroin (0–30 min), and only attenuating the subsequent hyperactivity at the highest doses. It is suggested that certain opiates act on the mesolimbic dopaminergic pathway at the level of the cell bodies in the VTA, but more critically in the N.Acc., possibly on opiate receptors postsynaptic to the dopamine neurons.

References (22)

  • E.M. Joyce et al.

    The behavioral effects on enkephalin analogues injected into the ventral tegmental area and globus pallidus

    Brain Res

    (1981)
  • Cited by (68)

    • Viral vector-mediated gene therapy for opioid use disorders

      2021, Experimental Neurology
      Citation Excerpt :

      HSV vectors expressing MnSOD into the PAG reduced morphine withdrawal syndrome, and suppressed the upregulation of mitochondrial superoxide and endoplasmic reticulum stress markers (glucose-related protein 78 (GRP78) and activating transcription factor 6 alpha (ATF6α)) in the PAG, suggesting that overexpression of MnSOD by HSV vectors may relieve opioid dependence (Iida et al., 2017). Opiate use increases locomotion in animals (Amalric and Koob, 1985). Morphine-induced locomotion was significantly lower in M5 muscarinic receptor knockout mice compared with wildtype mice (Steidl and Yeomans, 2009).

    • Progress in opioid reward research: From a canonical two-neuron hypothesis to two neural circuits

      2021, Pharmacology Biochemistry and Behavior
      Citation Excerpt :

      Pretreatment with α-flupenthixol (a non-selective DA receptor antagonist) can block morphine CPP induced by intra-VTA morphine injections in rats with a prior history of morphine exposure, but not in naive rats (Nader and van der Kooy, 1997). In addition , morphine can also be self-administered directly into the NAc by rats and mice (Amalric and Koob, 1985; David and Cazala, 2000; Olds, 1982) and intra-NAc microinjections of methylnaloxonium (a peripherally limited opioid antagonist) block heroin-induced hyperlocomotion in rats (Amalric and Koob, 1985), suggesting an important role of the mesolimbic DA system in opioid reward and addition-relation behavior. Furthermore, opioid-induced molecular and cellular plasticity in VTA GABAergic synapses onto DA neurons have been correlated with learning and drug memory, and therefore, it has been suggested that this type of neuroplasticity might promote compulsive opioid-taking and opioid-seeking behavior (Langlois and Nugent, 2017; Mazai-Robison and Nestler, 2012).

    • Dopamine D3 receptor-based medication development for the treatment of opioid use disorder: Rationale, progress, and challenges

      2020, Neuroscience and Biobehavioral Reviews
      Citation Excerpt :

      In addition, the non-selective DA antagonists alpha-flupenthixol and haloperidol significantly decrease cocaine, but not heroin, self-administration (Ettenberg et al., 1982; van Ree and Ramsey, 1987), suggesting that cocaine and heroin rewards are mediated by different mechanisms. In addition, morphine can be self-administered directly into the NAc by rats and mice (Amalric and Koob, 1985; David and Cazala, 2000; Olds, 1982) and intra-NAc microinjections of the peripherally limited opioid antagonist methylnaloxonium can block heroin-induced hyperlocomotion in rats (Amalric and Koob, 1985). In contrast, pharmacological blockade or downregulation of NAc dopamine D1 receptors (D1Rs) attenuates cocaine but not heroin self-administration (Gerrits et al., 1994; Pisanu et al., 2015).

    • In vitro and in vivo pharmacological characterization of the synthetic opioid MT-45

      2020, Neuropharmacology
      Citation Excerpt :

      Nevertheless, the involvement of the serotonergic system in the sequence of events triggered by mu-opioid receptor excitation cannot be denied, as serotonergic antagonists are able to block hyperlocomotion induced by morphine (Li et al., 2013). Regardless, in our study naloxone was effective in blocking the increase in locomotion induced by morphine and MT-45, based on the accelerod and spontaneous locomotion tests (data not shown) that prove the central role played by mu-opioid receptors in controlling motor performance in mice (Amalric and Koob, 1985; Gurtu, 1990). Interestingly, our data demonstrates that in the drag test the administration of 15 mg/kg of MT-45 decreased the number of steps to 50%, while the same dose of morphine was less effective.

    • Opioid-induced rewards, locomotion, and dopamine activation: A proposed model for control by mesopontine and rostromedial tegmental neurons

      2017, Neuroscience and Biobehavioral Reviews
      Citation Excerpt :

      In addition, morphine infusions into the NAcc, where high densities of opioid receptor subtypes are expressed (Erbs et al., 2015; Kitchen et al., 1997; Mansour et al., 1987) − downstream from dopaminergic synapses − support self-administration in rats and mice (Olds, 1982; David and Cazala 2000). Injections of the opioid antagonist methylnaloxonium into the NAcc, for example, have been shown to block locomotion induced by systemic heroin in rats (Amalric and Koob, 1985). However, while DA is not necessary for opioid-induced locomotion in rats, chronic blockade of dopaminergic transmission by either mesolimbic 6-OHDA lesions (Stinus et al., 1985) or prolonged systemic neuroleptic drugs (Stinus et al., 1986) results in supersensitivity to locomotion induced by NAcc injections of morphine, suggesting that a functional DA system in fact reduces sensitivity to NAcc opioid-induced locomotion.

    View all citing articles on Scopus
    View full text